Journal Club
July/August 2021: Comparing Dolutegravir or Darunavir in combination with Zidovudine or Tenofovir for second-line HIV treatment: Results of the NADIA Trial in Uganda, Kenya, and Zimbabwe
Article and Study Summary: Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. Published in: N Engl J Med 2021;385(4):330-341. https://www.nejm.org/doi/full/10.1056/NEJMoa2101609 Authors: Paton NI, Musaazi J, Kityo C, et al. Summary:...
June 2021: Multimonth Dispensing of up to 6 Months of Antiretroviral Therapy in Malawi and Zambia
Article and Study Summary Multimonth dispensing of up to 6 months of antiretroviral therapy in Malawi and Zambia (INTERVAL): a cluster-randomised, non-blinded, non-inferiority trial. Published in: Lancet Glob. Health. 2021;9(5):e628-e638....
May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...
